Only 20 per cent of men over 50 would opt for surgical treatment if faced with localised prostate cancer, according to a study by Plymouth University.
Mar 14, 2016
0
0
Approximately 14 percent of men will be diagnosed with prostate cancer at some point in their lifetimes, according to the National Institutes of Health. Radiation therapy traditionally has been a primary treatment for the ...
Mar 10, 2016
0
6
Whitehead Institute researchers have created a hydrogel scaffold replicating the environment found within the human breast. The scaffold supports the growth of human mammary tissue from patient-derived cells and can be used ...
Mar 1, 2016
0
3
Researchers at UT Southwestern Medical Center have determined that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85 percent accuracy, a finding that may lead to real-time ...
Feb 26, 2016
0
2
Debiopharm International SA (Debiopharm), part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced a collaboration in order to supply triptorelin pamoate 3.75 mg 1-month formulation for patients ...
Jan 14, 2016
0
0
Obesity has direct consequences on health and is associated with the onset of aggressive cancers, but the mechanisms underlying this phenomenon are little known. Researchers from the Institut de Pharmacologie et Biologie ...
Jan 13, 2016
0
56
Childhood cancer survivors are at heightened risk of a wide range of autoimmune diseases, reveals research published online in the Annals of the Rheumatic Diseases.
Nov 10, 2015
0
28
A new and important genetic discovery, which sheds light on how prostate cancers develop and spread, has been made by an international research team led by scientists at The University of Nottingham.
Oct 26, 2015
0
25
Older black men with localized prostate cancer were more likely to have poorer quality care, incur higher costs and have worse postoperative outcomes than white men but that did not translate to worse overall or cancer-specific ...
Oct 22, 2015
0
11
Blood pressure medication could help protect men from complications arising from radiotherapy for prostate cancer, a new study by researchers at the University of Dundee has found.
Oct 22, 2015
0
26
